Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review focuses on the immunologic-based skin conditions that can result from β-blocker use, emphasizing potential adverse dermatologic effects rather than their therapeutic benefits.

This study found that livedoid and acro-ischemic skin manifestations were significantly associated with severe COVID-19, while chilblains-like eruptions appeared in less severe cases.

This study provides evidence-based recommendations for the off-label use of topical vitamin D in treating certain skin conditions, but highlights the need for higher quality studies for further validation.

This case report documents a 61-year-old woman treated with erlotinib who experienced the rare side effect of cicatricial alopecia.

In this study, two dialysis patients with high plasma silicon levels exhibited symptoms like painful skin eruptions and unusual hair growth, suggesting silicon may influence calcium metabolism similarly to aluminum.

In this study, the first case of a persistent curly hair phenotype was reported with nivolumab treatment in a patient with metastatic squamous cell lung cancer.

This case report describes a 17-month-old girl with a history of itching skin, hair thinning, swelling, growth delay, anemia, and protein deficiency amidst potential food allergies and other health issues.

This study found that urticaria, psoriasis, and allergic/irritant contact dermatitis were more commonly diagnosed during the COVID-19 pandemic period, while acne and some other dermatological conditions decreased compared to before the pandemic.

This article discusses common dermatologic side effects of psychopharmacologic agents such as eruptions, urticaria, and photosensitivity, but it reports no new research findings.

This study found that dermatological manifestations in HIV-positive individuals, such as infectious and non-infectious dermatoses, were significantly associated with CD4 T cell count.

This study highlights that although mogamulizumab is highly effective for treating mycosis fungoides and Sézary syndrome, it frequently causes a variety of rashes as side effects.

This case report describes erosive pustular dermatosis of the scalp in a patient undergoing gefitinib treatment for lung cancer, and reviews literature on drug-induced cases of this rare condition.

In this case report, a 21-year-old woman's Fox-Fordyce disease was successfully controlled using topical 0.1% tretinoin cream.

In this study, a combined therapy of nicotinamide and green tea polyphenols was reported to improve EGFR inhibitor-related skin toxicity and patient quality of life, suggesting it merits further investigation.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

In this case report, discontinuing finasteride improved a facial rash potentially caused by drug-induced photosensitivity.

This review summarizes current knowledge on cutaneous symptoms in COVID-19, emphasizing their potential prognostic and therapeutic implications, but reports no new clinical findings.

This case report describes a 2-month-old infant with a severe seborrhea-like skin eruption and respiratory distress, similar to symptoms that led to a sibling's death from Gram-negative septicemia.

In this cross-sectional study of COVID-19 positive patients in Bangladesh, researchers found that maculo-papular eruptions were the most common dermatological manifestation, with other prevalent conditions including chilblain-like eruptions, urticarial lesions, and petechiae/purpura.

This review details skin conditions in children and adolescents related to the SARS-CoV-2 pandemic, emphasizing mask-related acne and various cutaneous manifestations linked to infection and vaccination, with most being mild or nonspecific.

This chapter reviews various hair disorders, focusing on androgenetic and scarring alopecias, and discusses management strategies, but presents no new research findings.

This case report describes a patient who developed PRIDE syndrome-associated skin issues, including a pruritic papulopustular rash and alopecia, after starting treatment with the EGFR inhibitor erlotinib.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

This article discusses skin lesions in chronic graft-versus-host disease and highlights the importance of coordinated care between haematologists and dermatologists for effective management; it presents no new clinical results.

In Ethiopia, this study found that certain skin and mucous membrane disorders, particularly oral conditions, were statistically related to HIV infection and may assist in early detection of the disease.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

This report describes a rare case of Graham-Little–Piccardi–Lassueur syndrome in a 46-year-old male, highlighting its typical features such as scarring alopecia and lichenoid follicular eruptions.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.